GSK
  • About
  • Press Releases
    Latest
    English 259
  • Assets
    Images
    Files
    Other
  • Resources
    Website
    facebook twitter youtube linkedin instagram
GSK
2 years ago ⋅ English ⋅ 4 min read
Newsroom

Jesduvroq (daprodustat) approved by US FDA for anaemia of chronic kidney disease in adults on dialysis

For media and investors onlyJesduvroq (daprodustat) approved by US FDA for anaemia of chronic kidney disease in adults on dialysis- Jesduvroq is the only oral HIF-PHI approved in the US... Read More

GSK
2 years ago ⋅ English ⋅ 2 min read
Newsroom

GSK delivers strong 2022 performance with full year sales of £29.3 billion +19% AER, +13% CER; Total EPS 371.4p >100% Adjusted EPS of 139.7p +27% AER, +15% CER from continuing operations

For media and investors onlyGSK delivers strong 2022 performance with full year sales of £29.3 billion +19% AER, +13% CER; Total EPS 371.4p >100% Adjusted EPS of 139.7p +27% AE... Read More

GSK
2 years ago ⋅ English ⋅ 3 min read
Newsroom

Benlysta granted Orphan Drug Designation by US FDA for the potential treatment of systemic sclerosis

For media and investors onlyGSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Benlysta (belimumab), a B... Read More

GSK
2 years ago ⋅ English ⋅ 4 min read
Newsroom

VidPrevtyn Beta COVID-19 booster vaccine, developed by Sanofi and GSK, approved for use in Great Britain

For media and investors only- SARS-CoV-2 spike protein (B.1.351 strain) vaccine is the first and only protein-based variant COVID-19 booster vaccine approved in Great Britain and the Eu... Read More

GSK
2 years ago ⋅ English ⋅ 6 min read
Newsroom

GSK and Wave Life Sciences announce collaboration to drive discovery and development of oligonucleotide therapeutics focusing on novel genetic targets

For media and investors only- Collaboration brings together Wave’s PRISMTM oligonucleotide platform and GSK’s expertise in genetics and genomics- GSK to advance up to eight... Read More

GSK
2 years ago ⋅ English ⋅ 2 min read
Newsroom

GSK announces new global headquarters in central London

For investors and media only- Location offers closer proximity to UK capital’s fast-growing global Life Sciences hub, Knowledge Quarter and world-class academic institutions- Buil... Read More

  • ‹
  • 1
  • 2
  • ...
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • ...
  • 43
  • 44
  • ›

Wire Association

© Copyright 2025
Wire Association. All rights reserved.
Helpful Links
  • Login
  • Home
  • About
  • Contact
Press Releases
  • Pricing
  • News Center
  • Editorial Guidelines
  • Editorial Team
Other
  • Terms & Conditions
  • Privacy Policy
  • Sitemap